# ZERIT XR
> **NDA021453** · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2002-12-31
## Drug
- **FDA Application Number:** NDA021453
- **Application type:** New Drug Application
- **Brand name:** ZERIT XR
- **Generic name:** Stavudine
- **Active ingredients:** STAVUDINE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** BRISTOL MYERS SQUIBB
- **First approval:** 2002-12-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021453)
---
*MORVS · CC0 1.0*